Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...

Markets didn't move much as 2019 comes to a close. The final day of 2019 didn't bring a lot of action on Wall Street, as investors seemed content to celebrate what's been an extremely strong year for ...

Aug 8 (Reuters) - Canadian pot firm Canopy Growth (WEED.TO), opens new tab reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger ...

(Reuters) -Pot producer Canopy Growth reported a smaller second-quarter adjusted core loss on Thursday on the back of cost cuts. The company has been grappling with liquidity issues and has taken ...

Canopy Growth Corp.'s announcement earlier Tuesday that it has sold its 13.2% stake in Australian producer AusCann for proceeds of C$6 million ($4.8 million) is a sign that the Canadian company is ...

(Reuters) -Canopy Growth again raised doubts about its ability to stay afloat as the Canadian pot producer's loss-making streak continued in the first quarter. Despite a strong start following the ...

Canopy Growth Corp, on Friday reported a larger adjusted core loss for the fourth quarter, as demand for cannabis fell from COVID-19 lockdown-induced highs, sending shares of the Canadian pot producer ...

ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...

Nov 9 (Reuters) - Pot producer Canopy Growth WEED.TO reported a smaller second-quarter adjusted core loss on Thursday on the back of cost cuts. Cannabis companies have been cutting costs and taking ...